Business
Perimeter Medical Imaging AI Announces CEO Transition and New Member of the Board of Directors
Perimeter Medical Imaging AI Announces CEO Transition and New Member of the Board of Directors ...
About this update from Perimeter Medical Imaging Ai Inc
[{"type":"text","content":"\n \n \n \n Perimeter Medical Imaging AI Announces CEO Transition and New Member of the Board of Directors\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntaj{\nTEXT-ALIGN: JUSTIFY\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n TORONTO\n \n and\n \n DALLAS\n \n \n ,\n \n \n June 5, 2023\n \n \n /CNW/ - (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) – Perimeter Medical Imaging AI, Inc. (\"Perimeter\" or the \"Company\") – a commercial-stage medical technology company – announced that\n \n Jeremy Sobotta\n \n has resigned as Chief Executive Officer of the Company, effective\n \n June 15, 2023\n \n , for personal reasons.\n \n \n \n \n \n \n \n \n \n Perimeter has also announced that the Board of Directors has appointed\n \n Adrian Mendes\n \n as Chief Executive Officer, effective immediately. Mr. Sobotta will work closely with Mr. Mendes over the coming weeks to ensure a smooth transition of responsibilities. Mr. Mendes is an experienced technology executive with 25 years of experience building and scaling technology companies across many different industries. Most recently, he was the Chief Operating Officer at Groq Inc, an AI hardware company, which he joined shortly after formation in 2016 and helped scale to one of the leading startups in that space.\n \n \n In addition, Perimeter announced that\n \n Josh Vose\n \n , MD, MBA has been appointed to its Board of Directors, effective immediately. Dr. Vose is an experienced medical device executive and corporate director with a longstanding history in scaling novel surgical technologies, and particularly in breast oncology and reconstruction. Most recently, Dr. Vose served as CEO and Board Director at SIA Health, leading the company through its Series B financing, the commercial growth of DuraSorb®, and acquisition by Integra LifeSciences (NASDAQ: IART).\n \n \n \n Suzanne Foster\n \n , Chair of Perimeter's Board of Directors commented, \"We are grateful for Jeremy's many contributions and service to Perimeter, particularly his prudent management of the Company's finances as the busin...